31 May 2022 Precirix strengthens patent portfolio of its precision radiopharmaceuticals platform Member news
25 May 2022 CureVac partners with myNEO to identify novel antigen targets for mRNA-based cancer vaccine development Member news
18 May 2022 KU Leuven announces collaboration and license agreement with Gilead Sciences for the development of new antivirals against the respiratory syncytial virus Member news
12 May 2022 Rejuvenate Biomed appoints life sciences leader Dr. Ajit Shetty as Chair of the Board of Directors to help guide international ambitions Member news
12 May 2022 Bone Therapeutics enters into exclusive reverse merger discussions with Medsenic Member news
10 May 2022 Augustine Therapeutics appoints Gerhard Koenig as Chairman of the Board, forms Clinical Advisory Board, and broadens therapeutic indications Member news
10 May 2022 UCB presents efficacy and safety results for zilucoplan and rozanolixizumab in generalized myasthenia gravis Member news
09 May 2022 Quality by Design (QbD) becomes QbD Group, consolidating its offerings to support the development of innovative life science products, “from idea to patient” Member news
More info? Ellen Telleir Communications Project Manager linkedin.com/in/ellentelleir/ ellen.telleir@biovia.be Contact us
